ERLOCIP 150MG TAB
Prescription Required
₹ 8,908.18
Inclusive of all taxes.
Couldn't load pickup availability
ERLOCIP 150MG TAB
Regular price
₹ 8,908.18
Regular price
Sale price
₹ 8,908.18
(-0%)
Unit price
per
ERLOCIP 150MG TAB
₹ 8,908.18
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Erlocip 150mg Tablet contains erlotinib, an epidermal growth factor receptor inhibitor that blocks signals involved in the growth of certain cancer cells.
Uses
Erlocip 150mg Tablet is used for the treatment of certain cancers.
- EGFR-positive non-small cell lung cancer.
- Pancreatic cancer in combination with other treatments.
Storage
- Store below 30°C in the original packaging.
- Protect from moisture and sunlight.
Safety Information
- Take on an empty stomach.
- Smoking may reduce the effectiveness of this medicine.
- Inform your doctor about lung, liver, kidney or eye problems and all other medicines.
- Use effective contraception during treatment.
Possible Side Effects
Possible side effects may include:
- Skin rash
- Diarrhoea
- Loss of appetite
- Fatigue
- Nausea
- Mouth sores
- Dry skin
- Eye irritation
- Rare serious lung or liver problems
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Erlocip is a prescription targeted anticancer medicine.
It should only be used under the supervision of a qualified oncologist.